Discovery of RNA‐Targeting Small Molecules: Challenges and Future Directions
MedComm · 2025-09 · 6 (9)
DOI: 10.1002/mco2.70342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.08.2025. Verfasst von Zhengguo Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: DP Technology Beijing China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Nova Program.
Abstract (Originalsprache)
RNA‐targeting small molecules represent a transformative frontier in drug discovery, offering novel therapeutic avenues for diseases traditionally deemed undruggable. This review explores the latest advancements in the development of RNA‐binding small molecules, focusing on the current obstacles and promising avenues for future research. We highlight innovations in RNA structure determination, including X‐ray crystallography, nuclear magnetic resonance spectroscopy, and cryo‐electron microscopy, which provide the foundation for rational drug design. The role of computational approaches, such as deep learning and molecular docking, is emphasized for enhancing RNA structure prediction and ligand screening efficiency. Additionally, we discuss the utility of focused libraries, DNA‐encoded libraries, and small‐molecule microarrays in identifying bioactive ligands, alongside the potential of fragment‐based drug discovery for exploring chemical space. Emerging strategies, such as RNA degraders and modulators of RNA–protein interactions, are reviewed for their therapeutic promise. Specifically, we underscore the pivotal role of artificial intelligence and machine learning in accelerating discovery and optimizing RNA‐targeted therapeutics. By synthesizing these advancements, this review aims to inspire further research and collaboration, unlocking the full potential of RNA‐targeting small molecules to revolutionize treatment paradigms for a wide range of diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DP Technology Beijing China.
- School of Mathematics Harbin Institute of Technology Harbin China.
- Center for Quantitative Biology Academy for Advanced Interdisciplinary Studies Peking University Beijing China.
- School of Pharmaceutical Sciences Peking University Beijing China.
- Program in Molecular Medicine The Hospital for Sick Children Research Institute Toronto Ontario Canada.
- Department of Molecular Genetics University of Toronto Toronto Ontario Canada.
ORCID-Profile: Zhengguo Cai
Förderung
- National Key Research and Development Program of China
- Beijing Nova Program
Zitieren
APA
Cai, Z., Ma, H., Ye, F., Lei, D., Deng, Z., Li, Y., Gu, R., & Wen, H. (2025). Discovery of RNA‐Targeting Small Molecules: Challenges and Future Directions. MedComm, 6(9). https://doi.org/10.1002/mco2.70342
Vancouver
Cai Z, Ma H, Ye F, Lei D, Deng Z, Li Y, et al. Discovery of RNA‐Targeting Small Molecules: Challenges and Future Directions. MedComm. 2025;6(9). doi:10.1002/mco2.70342
BibTeX
@article{Cai2025,
author = {Cai, Zhengguo and Ma, Hongli and Ye, Fengcan and Lei, Dingwei and Deng, Zhenfeng and Li, Yongge and Gu, Ruichu and Wen, Han},
title = {Discovery of RNA‐Targeting Small Molecules: Challenges and Future Directions},
journal = {MedComm},
year = {2025},
volume = {6},
number = {9},
doi = {10.1002/mco2.70342}
}
EUVIMED